What should ethics guidelines look like for clinical trials of in utero stem cell, protein, mRNA, and gene therapies to treat fetal disease?

Emily M Scire, Dario O Fauza

Open source

DOI
10.1016/j.sempedsurg.2026.151579
Published
2025-12
Container
Seminars in Pediatric Surgery
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.sempedsurg.2026.151579,
  title = {What should ethics guidelines look like for clinical trials of in utero stem cell, protein, mRNA, and gene therapies to treat fetal disease?},
  author = {Emily M Scire and Dario O Fauza},
  year = {2025},
  journal = {Seminars in Pediatric Surgery},
  doi = {10.1016/j.sempedsurg.2026.151579},
  url = {https://doi.org/10.1016/j.sempedsurg.2026.151579}
}

RIS

TY  - JOUR
TI  - What should ethics guidelines look like for clinical trials of in utero stem cell, protein, mRNA, and gene therapies to treat fetal disease?
AU  - Emily M Scire
AU  - Dario O Fauza
PY  - 2025
JO  - Seminars in Pediatric Surgery
DO  - 10.1016/j.sempedsurg.2026.151579
UR  - https://doi.org/10.1016/j.sempedsurg.2026.151579
ER  - 

APA

Scire, E. M., & Fauza, D. O. (2025). What should ethics guidelines look like for clinical trials of in utero stem cell, protein, mRNA, and gene therapies to treat fetal disease?. Seminars in Pediatric Surgery. https://doi.org/10.1016/j.sempedsurg.2026.151579

Source records